244 related articles for article (PubMed ID: 27649672)
1. Toxic dermatitis secondary to treatment with collagenase clostridium histolyticum for Dupuytren´s disease.
Sanjuan-Cervero R; Poquet-Jornet JE; Carrera-Hueso FJ
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3688-91. PubMed ID: 27649672
[TBL] [Abstract][Full Text] [Related]
2. [Collagenase Clostridum histolyticum in the management of Dupuytren's contracture].
Holzer LA; Holzer G
Handchir Mikrochir Plast Chir; 2011 Oct; 43(5):269-74. PubMed ID: 21935843
[TBL] [Abstract][Full Text] [Related]
3. Skin Laceration in Collagenase Clostridium histolyticum Treatment for Dupuytren's Contracture.
Sanjuan-Cervero R; Carrera-Hueso FJ; Oliver-Mengual S; Ramon-Barrios MA; Peimer CA; Fikri-Benbrahim N
Orthop Nurs; 2018; 37(2):144-153. PubMed ID: 29570549
[TBL] [Abstract][Full Text] [Related]
4. Collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture.
Kaplan FT
Drugs Today (Barc); 2011 Sep; 47(9):653-67. PubMed ID: 21971540
[TBL] [Abstract][Full Text] [Related]
5. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
[TBL] [Abstract][Full Text] [Related]
6. Collagenase clostridium histolyticum for Dupuytren's contracture.
Desai SS; Hentz VR
Expert Opin Biol Ther; 2010 Sep; 10(9):1395-404. PubMed ID: 20666587
[TBL] [Abstract][Full Text] [Related]
7. Clostridium histolyticum collagenase in the treatment of Dupuytren's contracture.
Azzopardi E; Boyce DE
Br J Hosp Med (Lond); 2012 Aug; 73(8):432-6. PubMed ID: 22875519
[TBL] [Abstract][Full Text] [Related]
8. ▾Xiapex for Dupuytren's contracture.
Drug Ther Bull; 2011 Dec; 49(12):138-41. PubMed ID: 22170410
[TBL] [Abstract][Full Text] [Related]
9. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
Smeraglia F; Del Buono A; Maffulli N
Br Med Bull; 2016 Jun; 118(1):149-58. PubMed ID: 27151958
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
Badalamente MA; Hurst LC; Benhaim P; Cohen BM
J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of Dupuytren's disease using collagenase from Clostridium histolyticum].
Martín-Ferrero MÁ; Simón-Pérez C; Rodríguez-Mateos JI; García-Medrano B; Hernández-Ramajo R; Brotat-García M
Rev Esp Cir Ortop Traumatol; 2013; 57(6):398-402. PubMed ID: 24071041
[TBL] [Abstract][Full Text] [Related]
12. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.
Gilpin D; Coleman S; Hall S; Houston A; Karrasch J; Jones N
J Hand Surg Am; 2010 Dec; 35(12):2027-38.e1. PubMed ID: 21134613
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Dupuytren's contracture by collagenase injection].
Foissac R; Camuzard O; Dumas P; Dumontier C; Chignon-Sicard B
Chir Main; 2013 Sep; 32(4):199-205. PubMed ID: 23856551
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study.
Gaston RG; Larsen SE; Pess GM; Coleman S; Dean B; Cohen BM; Kaufman GJ; Tursi JP; Hurst LC
J Hand Surg Am; 2015 Oct; 40(10):1963-71. PubMed ID: 26216077
[TBL] [Abstract][Full Text] [Related]
15. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
[TBL] [Abstract][Full Text] [Related]
16. Skin graft loss resulting from collagenase clostridium histolyticum treatment of Dupuytren contracture: case report and review of the literature.
Swanson JW; Watt AJ; Vedder NB
J Hand Surg Am; 2013 Mar; 38(3):548-51. PubMed ID: 23391354
[TBL] [Abstract][Full Text] [Related]
17. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
Holzer LA; Holzer G
N Engl J Med; 2009 Dec; 361(26):2579; author reply 2579-80. PubMed ID: 20050321
[No Abstract] [Full Text] [Related]
18. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
Zhang P; Qin L
N Engl J Med; 2009 Dec; 361(26):2578-9; author reply 2579-80. PubMed ID: 20032329
[No Abstract] [Full Text] [Related]
19. Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P
Orthop Traumatol Surg Res; 2018 Oct; 104(6):901-905. PubMed ID: 30253866
[TBL] [Abstract][Full Text] [Related]
20. OPTIMAL INJECTION DEPTH FOR COLLAGENASE CLOSTRIDIUM HISTOLYTICUM DETERMINED BY ULTRASONOGRAPHY IN THE TREATMENT OF DUPUYTREN´S DISEASE.
Nagura I; Kanatani T; Harada Y; Inui A; Mifune Y; Kuroda R; Lucchina S
Acta Chir Plast; 2020; 62(3-4):64-67. PubMed ID: 33685199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
